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Methylomic profiling of cortex samples from completed
suicide cases implicates a role for PSORS1C3 in major
depression and suicide
TM Murphy1, B Crawford1, EL Dempster1, E Hannon1, J Burrage1, G Turecki2, Z Kaminsky3,4 and J Mill1,5
Major depressive disorder (MDD) represents a major social and economic health issue and constitutes a major risk factor for suicide.
The molecular pathology of suicidal depression remains poorly understood, although it has been hypothesised that regulatory
genomic processes are involved in the pathology of both MDD and suicidality. In this study, genome-wide patterns of DNA
methylation were assessed in depressed suicide completers (n= 20) and compared with non-psychiatric, sudden-death controls
(n= 20) using tissue from two cortical brain regions (Brodmann Area 11 (BA11) and Brodmann Area 25 (BA25)). Analyses focused on
identifying differentially methylated regions (DMRs) associated with suicidal depression and epigenetic variation were explored in
the context of polygenic risk scores for major depression and suicide. Weighted gene co-methylation network analysis was used to
identify modules of co-methylated loci associated with depressed suicide completers and polygenic burden for MDD and suicide
attempt. We identified a DMR upstream of the PSORS1C3 gene, subsequently validated using bisulfite pyrosequencing and
replicated in a second set of suicide samples, which is characterised by significant hypomethylation in both cortical brain regions in
MDD suicide cases. We also identified discrete modules of co-methylated loci associated with polygenic risk burden for suicide
attempt, but not major depression. Suicide-associated co-methylation modules were enriched among gene networks implicating
biological processes relevant to depression and suicidality, including nervous system development and mitochondria function. Our
data suggest that there are coordinated changes in DNA methylation associated with suicide that may offer novel insights into the
molecular pathology associated with depressed suicide completers.
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INTRODUCTION
Major depressive disorder (MDD) represents a major social and
economic health issue, affecting over 350 million people
worldwide.1 MDD is associated with a reduced life expectancy
and constitutes a major risk factor for suicide, a leading cause of
mortality among young people in developed countries.1 Every
year, almost one million people die from suicide globally with
suicide attempts up to 20 times more frequent than completed
suicide.1 The risk for suicidal acts is multifactorial, and consists of a
range of biological, psychiatric, psychosocial and cultural risk
factors.2 Currently, the molecular pathology of MDD leading to
suicide remains poorly understood.
To date, large-scale genome-wide association studies of MDD
have, with the exception of two loci associated with MDD in a
large cohort of Chinese women,3 failed to identify robust
replicated genetic loci.3,4 These results indicate that the risk of
MDD is unlikely to be increased by the effect of one or a few
single-nucleotide polymorphisms but instead is highly polygenic
in nature.3 Despite advances in understanding the genetic
epidemiology of MDD, little is known about the mechanisms by
which MDD risk variants mediate disease susceptibility in the
brain.5,6 Recent studies have started to examine the role of
epigenetic processes—acting to regulate gene expression via
modifications to DNA, histone proteins and chromatin—in a
number of complex disease phenotypes.7 The epigenome is
potentially malleable—changing with age and in response to
specific environmental and psychosocial factors8—providing a
mechanism for the interaction between genotype and the
environment.9 Epigenetic processes, including DNA methylation,
have recently been implicated in the aetiology of numerous
mental health disorders,10–14 including MDD15–17 and suicidal
behaviour.18–21
To date, studies examining DNA methylation differences
associated with MDD have primarily used peripheral tissue15–17
and few have examined DNA methylation changes in the brains of
depressed individuals22–24 and depressed suicide completers.22,25
Here, we describe a study of MDD suicide-associated methylation
variation in matched cortical brain samples and its relationship to
MDD and suicide attempt polygenic risk scores (PRS's). We profiled
DNA methylation in two cortical brain regions (Brodmann Area 11
(BA11) and Brodmann Area 25 (BA25)) obtained from matched
depressed suicide completers (n= 20) compared with non-
psychiatric, sudden-death controls (n= 20). We identify evidence
for altered DNA methylation in MDD suicide cases and MDD
suicide-associated co-methylation modules that are associated
with increased polygenic burden for suicide attempt.
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MATERIALS AND METHODS
Samples
Tissue (n= 75) from two regions of the cortex (BA11, n=40 and BA25, n=35)
from 20 MDD suicide cases and 20 non-psychiatric sudden-death controls
were obtained from the Douglas Bell Canada Brain Bank (http://
douglasbrainbank.ca/; see Supplementary Table S1 for further details).
Cases and controls did not differ significantly by ethnic background
(P= 0.748; Fisher’s exact test). BA25 is rostrally bound by the prefrontal
BA11 region. Brain specimens used in this study were collected post-
mortem following consent obtained from next-of-kin. The left hemisphere
was kept frozen at − 80 °C and cut into consecutive 1 cm-thick coronal
sections that are then snap-frozen in liquid nitrogen and stored at − 80 °C.
Cases in this study were individuals who died by suicide as determined by
the coroner and following psychological autopsies, which met the criteria
for MDD as described elsewhere.26,27 Controls were individuals who died
suddenly in motor vehicle accidents or by cardiac arrest and did not have
evidence of axis I disorders. Cases and controls were group-matched
according to gender, age, post-mortem interval and tissue pH. The
collection of brain tissue for banking by the Douglas Bell Canada Brain
Bank is approved by the Douglas Mental Health University Institute’s
Research Ethics Board (REB), and this study was approved by the University
of Exeter Medical School REB. Genomic DNA was isolated from tissue
samples using a standard phenol–chloroform extraction protocol and
tested for purity and degradation using spectrophotometry and agarose
gel electrophoresis.
Methylomic profiling
Genomic DNA (500 ng) was treated in duplicate with sodium bisulfite
using the EZ-96 DNA Methylation Kit (Zymo Research, Irvine, CA, USA)
following the manufacturers’ standard protocol. DNA methylation was
quantified using the Infinium HumanMethylation450 BeadChip Array
(Illumina, San Diego, CA, USA) as previously described.28 Samples were
randomised throughout all experimental procedures to avoid batch
effects. The Genome Studio software (Illumina) was used to extract signal
intensities for each probe and perform initial quality control. Further
quality-control checks, quantile normalisation and separate background
adjustment of methylated and unmethylated intensities of type I and II
probes were employed using the wateRmelon package in R (available from
the bioconductor www.bioconductor.org).28 Probes on the X- and
Y-chromosomes were used to confirm sample sex. Comparison of 65
single-nucleotide polymorphism probes on the array confirmed that
matched tissues were sourced from the same individual. All samples
passed stringent quality-control measures (41% of sites with a detection
P-value40.01). Probes with a detection P-value40.01 in at least 1% of
samples and/or a beadcount o3 in 5% of samples were removed across
all samples. Nonspecific probes and probes on the X- and Y-chromosomes
were removed.29,30 The final analyses included 416 876 probes, and 75
samples (40 samples for brain region BA11 (20 MDD suicide cases and 20
non-psychiatric sudden-death controls) and 35 matched BA25 samples
taken from the same individuals (17 MDD suicide cases and 18 non-
psychiatric sudden-death controls)). Raw Illumina 450 K array data are
deposited in the Gene Expression Omnibus database (accession number:
GSE88890).
Estimating differential brain cell counts
The R package (available at www.cran.r-project.org), Cell EpigenoType
Specific mapper, designed for the quantification and normalisation of
differing neuronal proportions in genome-wide DNA methylation data sets,
was used to estimate brain cellular heterogeneity in all samples as
previously described.31
Data analyses of genome-wide DNA methylation
Statistical analyses were performed using R statistical package (version
3.2.1). The Beta value (β) is a ratio between methylated probe intensity and
total probe intensities (sum of methylated and unmethylated probe
intensities) and ranges from 0 to 1. Linear regression was used to examine
differences in DNA methylation scores (reported as change in Beta value
(Δβ)) between MDD suicide cases and controls at each CpG site,
controlling for potential confounders (age, gender and estimated neuronal
cell composition). Overlapping differentially methylated positions (DMPs)
between brain regions (BA11 and BA25) was assessed by examining the
correlation of effect sizes (mean adjusted beta difference) across the two
brain regions of matched individuals using Pearson’s Correlation
coefficient. We identified consistent MDD-associated DNA methylation
differences across both brain regions by fitting a linear mixed-effect model
using the lme4 R package (available at https://cran.r-project.org32). Where
β (DNA methylation value) is the response variable, brain region and
sample ID were included in the model as random effects and diagnosis,
age, gender and cellular composition were included in the model as fixed
effects.
Region-based analysis
To identify differentially methylated regions (DMRs) in our data, we used
the Python module Comb-p33 to group spatially correlated DMPs (seed P-
value o1× 10− 2, minimum of three probes) at a maximum distance of
500 bp in each brain tissue. DMR P-values were corrected for multiple
testing using Šidák correction.34
Bisulfite pyrosequencing
We used bisulfite pyrosequencing to confirm MDD-associated differential
DNA methylation across the PSORS1C3-associated DMR (spanning a region
(chromosome 6:31148343–31148604 (hg19)), which encompasses 17 CpG
sites (10 of which overlap with those measured by the 450 k array
experiment)). A single amplicon (261 bp) was amplified using primers
designed using the PyroMark Assay design software (Qiagen, Manchester,
UK). Samples were bisulfite–polymerase chain reaction-amplified (HOT
FIREPol DNA Polymerase, Solis Biodyne, Tartu, Estonia) using the primers
and assay conditions in Supplementary Table S2 and sequenced using two
sequencing primers to maximise coverage across the DMR using the
Pyrosequencing Pyromark Q24 system (Qiagen). Correlation between the
mean DNA methylation levels at 10 CpG sites quantified by bisulfite
pyrosequencing and the Illumina 450k array was calculated using
Pearson’s correlation coefficient. However, changes in DNA methylation
across all 17 CpG sites between cases and controls across both brain
regions were assessed by fitting a linear mixed-effect model by maximum
likelihood using lme4 R package (as described above).
Genotyping
Genomic DNA (200 ng) from each individual brain sample (n= 40) was
genotyped using the Illumina HumanOmniExpress BeadChip (Illumina). All
samples were randomised with respect to gender and disease status to
avoid batch effects. Illumina Genome Studio was used to call genotypes
(using the HumanOmniExpress-12v1_C.egt cluster file) with the default
GenCall cutoff of 0.15. Sex was confirmed by checking the reported sex of
each individual against that predicted by the genetic data as described
previously.35
Polygenic risk scoring
PRS's were calculated using the P-values and log odds ratios from (i) the
most recent Psychiatric Genetics Consortium genome-wide association
study (GWAS) of MDD4 and (ii) a recent GWAS of suicide attempt.36 Risk
scores were obtained following the method described by Purcell and
colleagues37 using PLINK.38 For each individual, scores were generated
from single-nucleotide polymorphisms selected by P-value-informed
clumping (P-valueso0.05) in PLINK,38 with a linkage disequilibrium cutoff
of r2 = 0.1 within a 500-kb window. The numbers of single-nucleotide
polymorphisms included in PRS for MDD, and suicide attempt calculation
were 5267 and 3547, respectively.
Weighted gene co-methylation network analysis
Network analysis was performed on residuals obtained after regressing out
confounders (age, gender and estimated brain cell proportions) for each
brain region (BA11 and BA25) separately using weighted gene co-
methylation network analysis (WGCNA).39 For each brain region pairwise
correlations were used to identify modules of highly co-methylated
probes, independent of disease status as described previously.11 Briefly, an
unsigned network was created using the blockwiseModules function based
on a block size of 5000 and using a soft threshold parameter of 6. Each
module was then labelled with a unique colour identifier and the module
eigengene (ME) for each module (a weighted average methylation profile)
was calculated based on the first principal component of the methylation
matrix. To identify modules associated with diagnosis, a t-test was used to
compare the mean ME values between cases and controls. Pearson’s
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correlation coefficients were used to examine association between ME
values and continuous variables (MDD PRS and suicide attempt PRS). The
module membership of each probe was calculated as the correlation
between DNA methylation values and ME values. Probes with an absolute
module membership value ⩾ 0.8 were used to identify the ‘hub’ genes in
each module. Modules and their ‘hub’ genes were visualised using
Cytoscape v3.2.40 A previously described logistic regression approach41
was used to test whether genes (Illumina UCSC gene annotation)
annotated to probes in disease-associated modules predicted pathway
membership while controlling for the number of probes annotated to each
gene. Briefly, pathways were downloaded from the Gene Ontology (GO)
website (http://geneontology.org/) and genes with at least one Illumina
probe annotated to it and which mapped to at least one GO pathway were
included. Pathways were filtered to those containing between 10 and 2000
genes, and a list of nominally significant pathways (Po0.05) was identified
as described previously.41
Replication analyses in an independent prefrontal cortex sample
Post-mortem prefrontal cortical tissue samples were obtained from the
National Institute of Child Health and Human Development Brain and
Tissue Bank for Developmental Disorders at the University of Maryland as
described in detail elsewhere.18 These brain samples include suicide cases
whose psychiatric diagnoses are unclear. DNA methylation data were
available from sorted neuronal and non-neuronal cells obtained from 23
suicide cases and 33 non-suicide controls. Cell sorting was performed as
described previously.31 DNA methylation was quantified using the Illumina
Infinium HumanMethylation450 BeadChip array, with data normalisation
and pre-processing performed using wateRmelon as described above.
Brown’s method42 was used to calculate a combined P-value for the
PSORS1C3-associated region in the suicide replication cohort.
RESULTS
Brief overview of experimental approach
An overview of the methodological approach used in this study is
given in Supplementary Figure 1. Briefly, we assessed genome-
wide patterns of DNA methylation in two cortical brain regions
(BA11 and BA25) obtained from depressed suicide completers
(n= 20) and matched non-psychiatric, sudden-death controls
(n= 20) using the Illumina 450 K HumanMethylation microarray
(450 K array). Pre-processing, normalisation and stringent quality
control were performed as previously described28 (see Materials
and Methods for specific details). Our initial analyses focused on
identifying DMPs and DMRs associated with MDD suicide cases
compared with controls in both brain regions separately
(Supplementary Figure 1A). We subsequently validated altered
DNA methylation across a specific DMR using bisulfite pyrose-
quencing, and confirmed this association in an independent
replication cohort (Supplementary Figure 1B). Next, PRS's were
calculated for each sample using results from the most recent
Psychiatric Genetics Consortium GWAS of MDD4 and a recent
GWAS of suicide attempt36 (Supplementary Figure 1C). Finally, a
system-level approach was used to identify networks of co-
methylated loci associated with depressed suicide completion, in
addition to polygenic burden for MDD and suicide attempt
(Supplementary Figure 1D).
Suicide-associated DMPs in cortical regions BA11 and BA25
We assessed genome-wide patterns of DNA methylation in MDD
suicide cases compared with non-psychiatric controls in two brain
regions (BA11 and BA25) obtained from the same individuals
using linear regression, controlling for age, gender and estimated
neuronal proportion (see Materials and Methods). No DMP
reached experiment-wide significance (Po1.66 × 10− 7, threshold
estimated from permutation analysis in a large data set (n= 675
individuals) generated as part of an on-going study in our
group);43 several showed suggestive evidence for association
(Po5 × 10− 5). The 10 most significantly differentially methylated
loci identified in the MDD suicide group for brain regions BA11
and BA25 are listed in Supplementary Table S3 and include probes
in the vicinity of a number of loci previously implicated in
neuropsychiatric phenotypes. Next, we examined correlation of
effect sizes (mean adjusted beta difference) across the two brain
regions of matched individuals at (i) nominally significant
(Po0.05) BA25-associated DMPs (Figure 1a) and (ii) nominally
significant (Po0.05) BA11-associated DMPs (Figure 1b). The mean
adjusted beta differences at these loci were significantly positively
correlated between brain regions (BA25 versus BA11: Pearson’s
r= 0.29, Po2.2 × 10− 16; BA11 versus BA25: Pearson’s r= 0.34,
Po2.2 × 10− 16), with even stronger correlations across brain
regions for DMPs showing large MDD suicide-associated
differences (Δβ⩾ 0.05; BA25 versus BA11: Pearson’s r= 0.8
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Figure 1. DNA methylation cross-tissue correlations. Correlation of effect sizes (mean adjusted beta difference) across the two brain regions of
matched individuals at (a) nominally significant (Po0.05) BA25-associated DMPs and (b) nominally significant (Po0.05) BA11-associated
DMPs. The mean adjusted beta differences at these loci were significantly positively correlated between brain regions (Po2.2 × 10− 16). In
addition, nominally significant DMPs exhibiting larger absolute beta differences (absolute Δβ⩾ 0.05; BA11 (n= 181); BA25 (n= 282) showed
strong positive correlations when compared across the two brain regions (Pearson’s r= 0.8, Pearson’s r= 0.87, respectively, shown in red).
BA11, Brodmann Area 11; BA25, Brodmann Area 25; DMP, differentially methylated position.
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(Po2.2 × 10− 16), BA11 versus BA25: Pearson’s r= 0.87
(Po2.2 × 10− 16), Figure 1).
Region-based analysis of altered DNA methylation in MDD suicide
completers
We used Comb-p33 to identify DMRs in MDD suicide cases
compared with controls. Our analysis identified two significant
(Sidak-corrected P-valueo0.05) DMRs in BA25 (Table 1); a DMR on
chromosome 13 in the promoter region of DNAJC15 (Sidak-
corrected P-value = 0.03) and a DMR overlapping exon 3 of the
SNAI3 gene on chromosome 16 (Sidak-corrected P-value = 0.005).
No significant DMRs were identified in BA11 after correcting for
multiple testing. Next, a cross-tissue DMR analysis was performed
to identify regions consistently associated with MDD in both brain
regions, using P-values obtained from fitting a linear mixed-effect
model across both brain regions. This analysis identified three
significant (Sidak-corrected P-valueo0.05) DMRs (Table 1); the
top-ranked DMR (spanning 13 CpG sites) is located in the
promoter region of the PSORS1C3 non-coding gene (Sidak-
corrected P-value = 8.02 × 10− 6, Figure 2). The PSORS1C3-asso-
ciated DMR is hypomethylated across all CpG sites in MDD suicide
cases compared with controls in both brain regions (Figure 2b). In
addition, we identified a DMR located in the third intron of the
TAPBP gene (Sidak-corrected P-value = 7.82 × 10− 5) and a DMR
located upstream in the promoter region of the ATP5G2 gene
(Sidak-corrected P-value = 0.02).
Validation and replication of the PSORS1C3-associated DMR
We next sought to technically validate our Illumina 450K array
data across the PSORS1C3 DMR using bisulfite pyrosequencing.
The mean DNA methylation estimated by bisulfite pyrosequen-
cing of the PSORS1C3-associated DMR was found to be strongly
correlated with the Illumina 450K array data (BA25: Pearson’s
r= 0.97 (Po2.2 × 10− 16); BA11 Pearson’s r= 0.9 (Po1.075 × 10− 13;
Figure 3), in both brain regions, and confirmed DNA hypomethy-
lation across the region (P= 0.029) in suicide cases compared with
controls at this locus (see Supplementary Table S4). We next
examined 450 k array DNA methylation measures across this
region in an independent set of prefrontal cortex (PFC) neuronal-
sorted suicide brain samples (suicide cases (n= 23) and non-
suicide controls (n= 33)). Consistent with our findings, we
observed reduced DNA methylation across all CpG sites present
in the DMR in suicide cases compared with non-suicide controls
(Figure 2c). Although overall patterns of DNA methylation did not
reach statistical significance (Brown’s P-value = 0.13), two CpG
sites within the DMR were significantly differentially methylated
between cases and controls (cg26818629 (P= 0.03); cg26668675
(P= 0.04), see Figure 2c; Supplementary Table S5). In contrast,
there were no differences in DNA methylation at this region in
DNA from non-neuronal-sorted cells obtained from the same
individuals (P40.1 for all sites; Supplementary Table S5), indicat-
ing that the effect was neuron-specific.
Modules of co-methylated loci are associated with MDD suicide
completers and suicide attempt PRS in brain region BA25
Two PRS for major depression and suicide attempt were
generated from the most recent Psychiatric Genetics Consortium
GWAS meta-analysis of MDD4 and a recent GWAS of suicide
attempt,36 respectively. PRS scores for both MDD (P= 0.01) and
suicide attempt (P= 0.07) were higher in MDD suicide cases
compared with controls (Supplementary Figure 2), highlighting
the utility of these scores. We next employed WGCNA39 to
undertake a systems-level approach to identify networks of co-
methylated modules associated with depressed suicide comple-
ters and MDD and suicide attempt PRS. WGCNA identified 80
modules of co-methylated probes in BA25 and 57 modules of co-
methylated probes in BA11. The ME was used to assess the
association between DNA methylation modules and phenotype
traits of interest (i.e., diagnosis, suicide attempt PRS score and
MDD PRS score). Five modules were found to be nominally
significantly (Po0.05) correlated with diagnosis in brain region
BA25 (Figure 4a), whereas only one module was associated with
diagnosis in brain region BA11 (mean difference in ME between
cases and controls (ΔME) = 0.11, P= 0.038). Interestingly, two MDD
suicide-associated BA25 modules (the ‘white’ module (n= 5581
probes): ΔME=0.14, P= 0.02 and ‘darkorange2’ module (n= 1980
probes): ΔME=− 0.13, P= 0.03) were also associated with a PRS
score for suicide attempt (‘white’ module: r= 0.35, P= 0.04,
‘darkorange2’ module: r=− 0.4, P= 0.02 ) but not a PRS for MDD
(Figure 4). Hub genes (absolute module membership⩾ 0.8) and
their intramodule connectivity for the ‘white’ and ‘darkorange2’
modules are illustrated in Figure 4c and Figure 4d, respectively.
To facilitate biological interpretation of these MDD suicide-
associated modules, we performed gene ontology enrichment
analysis on genes annotated to probes in both modules using a
logistic regression method previously described.41 The ‘darkor-
ange2’ module was highly enriched for biological pro-
cesses related to homophilic cell adhesion (GO:0007156,
P-value = 2.33 × 10− 9) and establishment of cell polarity
(GO:0030010, P-value = 8.13 × 10− 6). In contrast, the ‘white’
module was highly enriched for pathways related to nervous
system development (GO:0007399, P-value = 4.08 × 10− 6), chro-
matin modification (GO:0016568, P-value = 4.6 × 10− 6) and mito-
chondria function (GO:0005739, P-value = 6.04 × 10− 6). A full list of
all significantly (P-valueo0.05) enriched pathways in the ‘darkor-
ange2’ and ‘white’ modules are available in Supplementary
TableS6 and TableS7, respectively. These analyses suggest that
the coordinated changes in DNA methylation and suicide attempt
Table 1. Comb-p differentially methylated regional analysis
Brain region Hg19 Annotated gene (UCSC) No. of probes Slk P-value Sidak P-value
BA25
chr16:88744522–88744843 SNAI3 3 1.70E− 08 0.005
chr13:43597565–43598039 DNAJC15 4 1.71E− 07 0.030
Cross-tissue analysis (BA11 and BA25)
chr6:31148332–31148667 PSORS1C3 13 3.14E− 11 8.02E− 06
chr6:33280149–33280714 TAPBP 17 5.16E− 10 7.82E− 05
chr12:54070931–54071195 ATP5G2 6 6.37− 08 0.020
Abbreviations: BA11, Brodmann area 11; BA25, Brodmann area 25; Hg19, Human Genome version 19; UCSC, University of California, Santa Cruz Human
Genome Browser. Stouffer–Liptak–Kechris correction (slk); one-step Šidák (1967) multiple-testing correction.
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PRS may contribute to disease pathology associated with
depressed suicide completers.
DISCUSSION
In this study, we assessed genome-wide patterns of DNA
methylation in DNA obtained from MDD suicide cases compared
with non-psychiatric, sudden-death controls in two cortical brain
regions (BA11 and BA25) using the Illumina 450 K array. To our
knowledge, this represents the most extensive methylomic study
of depressed suicide completers using post-mortem brain tissue
to date.
We first examined site-specific genome-wide patterns of DNA
methylation in MDD suicide cases compared with controls.
Although no DMP reached experiment-wide significance, a
number of DMPs identified have been previously implicated in
neuropsychiatric phenotypes. For example, cg16292768 (intronic
region of the Clusterin gene and upstream of MIR6843), which is
hypomethylated in BA11 (P= 3.35 × 10− 5) of depressed suicide
cases compared with controls, is associated with neuritic amyloid
plaque burden, an early marker of Alzheimer’s pathology.44
Moreover, cg20434178, located in the promoter region of the
autism-associated DLX2 gene,45,46 is hypermethylated in BA25
(P= 5.4 × 10− 5) in MDD suicide cases compared with controls.
Figure 2. DNA hypomethylation of DMR upstream of the PSORS1C3 non-coding gene. (a) Idiogram of chromosome 6 with genomic
coordinates of DMR illustrated. The DMR—spanning 13 CpG sites—overlaps a CpG island (shown in blue). (b) PSORS1C3-associated DMR is
hypomethylated across all 13 CpG sites in MDD suicide cases compared with controls in both brain regions. (c) Consistent with our findings,
we observed DNA hypomethylation across all CpG sites present in the DMR in suicide cases compared with non-suicide controls in an
independent suicide brain replication cohort. Two CpG sites (*) within the DMR were significantly differentially methylated between cases and
controls (cg26818629 (P= 0.03); cg26668675 (P= 0.04)). DMR, differentially methylated region; MDD, major depressive disorder.
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DLX2 encodes a homeodomain-containing transcription factor
and has been implicated in the generation of GABAergic cortical
interneurons.47 A previous study examining DNA methylation
changes in post-mortem PFC brain samples from MDD patients
and controls identified DNA hypermethylation at the PRIMA1
gene, and a concurrent decrease in gene expression.24 Interesting,
cg23889730, a CpG site proximal to the PRIMA1 gene region
assessed in the MDD post-mortem brain study, was also
hypermethylated in MDD suicide cases compared with controls
(Δβ= 0.02, P= 0.04) in BA11 but not in BA25 in our study. Our data
further support a role for PRIMA1 in the pathogenesis of MDD.
To increase the power of our study to identify changes in DNA
methylation between cases and controls, and given that DNA
methylation at adjacent probes is often correlated, we employed
the regional-based analysis, comb-p, to identify DMRs. Our analysis
identified two DMRs in BA25: a DMR in a 5ʹ CpG island of the
DNAJC15 gene (Sidak-corrected P-value = 1.7 × 10− 7) and a DMR
overlapping exon 3 of the SNAI3 gene on chromosome 16 (Sidak-
corrected P-value = 1.7 × 10− 8); DNAJC15 is a mitochondrial
protein that has an important role in the regulation of the
mitochondrial function in macrophages and their response to
inflammatory stimuli.48 Interestingly, CpG island methylation of
the DNAJC15 gene and concurrent transcriptional silencing have
been previously reported,48,49 suggesting that changes in DNA
methylation at this locus are likely to alter gene expression levels.
Recently, mitochondrial dysfunction has been hypothesised to
have a role in the pathogenesis of MDD.50 SNAI3 is a member of
the SNAIL gene family, which have a role in mesodermal formation
during embryogenesis51 but has not previously been linked to the
pathogenesis of mental health disorders. In contrast to our finding
in brain region BA25, no significant DMRs were identified in region
BA11 from matched individuals. A cross-cortex DMR analysis
identified three regions consistently associated with MDD suicide
cases in both brain regions. The top-ranked DMR (spanning 13
CpG sites) is upstream of the PSORS1C3 non-coding gene and
overlaps a cluster of large intergenic non-coding RNAs associated
with the PSORS1C3 gene52 and is associated with a DNAse-
hypersensitivity region.53 The PSORS1C3-associated DMR is hypo-
methylated across all CpG sites in MDD suicide cases compared
with controls in both brain regions. We further validated this
finding using bisulfite pyrosequencing in the same samples and
confirmed reduced DNA methylation of the PSORS1C3 DMR in an
independent set of neuronal sorted post-mortem PFC samples
from suicide cases compared with non-suicide control subjects.
Although the function of the PSORS1C3 gene product remains
unknown, it is thought to potentially regulate nearby genes (for
example, POU5F1 and HLA-C), suggesting a prominent role in
immune system regulation.54 Moreover, PSORS1C3 is a known
psoriasis susceptibility gene further supporting a role in immune
system regulation.54 Of interest, we examined inter-individual
variation at the PSORS1C3-associated DMR using a recently
developed Blood Brain DNA Methylation Comparison Tool55 (data
not shown). DNA methylation at this DMR is significantly
correlated (r40.43, Po0.0001 at each CpG site) between blood
and multiple brain regions, suggesting that the DNA methylation
patterns observed in the brain may also be detected in peripheral
tissue.
Two additional MDD/suicide-associated DMRs were identified; a
DMR located in the third intron of the TAPBP gene (Sidak-
corrected P-value = 7.82 × 10− 5) and a DMR located upstream in
the promoter region of the ATP5G2 gene (Sidak-corrected
P-value = 0.02). The TAPBP gene, which is located within the
major histocompatibility complex on chromosome 6, encodes a
transmembrane glycoprotein that mediates interaction between
major histocompatibility complex class I molecules and the
transporter associated with antigen processing. In contrast, the
ATP5G2 gene encodes a subunit of mitochondrial ATP synthase.56
To the best of our knowledge, neither gene has been previously
implicated in the pathology of MDD or suicidal behaviour. Taken
together, our results provide evidence for a potential role for both
immune regulation and mitochondria dysfunction in suicide and
MDD. As DNA methylation can be influenced by specific genetic
variants (for example, methylation quantitative trait loci (mQTLs))
in cis or trans, we examined all five DMRs identified in the regional
analysis for evidence of the presence of mQTLs using our recently
published data set examining mQTLs in the developing and adult
human brain.57 We found no evidence of mQTLs in all DMR
regions identified, suggesting that the changes in DNA methyla-
tion observed are not a result of genetic background.
In order to examine associations between DNA methylation and
polygenic burden associated with both MDD and suicide, we
generated two PRS's for MDD and suicide attempt, respectively,
for each of the individuals profiled in this study. PRS scores for
both MDD and suicide attempt were higher in MDD suicide cases
compared with controls supporting the utility of these scores.
Next, we used WGCNA to identify networks of co-methylated
Figure 3. Technical validation of PSORS1C3-associated DMR using bisulfite pyrosequencing. Correlation of the mean DNA methylation values
(at 10 CpG sites) obtained from the 450 k array (y axis) and bisulfite pyrosequencing (x axis) for samples in the brain region (a) BA11 (Pearson’s
r= 0.97; P-valueo2.2 × 10− 16) and (b) BA25 (Pearson’s r= 0.97; P-value= 1.07 × 10− 13). BA11, Brodmann Area 11; BA25, Brodmann Area 25;
DMR, differentially methylated region.
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modules associated with depressed suicide completers and MDD
and suicide attempt PRS. Our analysis identified two MDD suicide-
associated BA25 modules (‘white’ module and ‘darkorange2’
module) that were also associated with a PRS score for suicide
attempt but not a PRS for MDD. Furthermore, disease-associated
co-methylation modules were enriched among gene networks,
implicating biological processes relevant to depression and
suicidality, including nervous system development and mitochon-
dria function. These findings further support a hypothesis of
mitochondria dysfunction in MDD and suicidal behaviour.
Despite the power of the methodological approaches used in
this study, there are several limitations. First, our analysis utilised a
small cohort of post-mortem brain samples (n= 75) and is thus
relatively underpowered to detect small changes in DNA
methylation. Despite this we were able to identify a number of
statistically significant DMRs. Moreover, we confirmed DNA
hypomethylation of our top-ranked DMR by both bisulfite
pyrosequencing and in post-mortem PFC samples obtained from
an independent suicide cohort. Second, in this study we used bulk
tissue from each brain region and cellular heterogeneity is a
potentially important confounder in DNA methylation
studies.31,58,59 However, we used a previously reported in silico
method to estimate the neuronal proportion in each sample and
included these estimates in our statistical models. Moreover, we
examined DNA methylation changes in our top-ranked DMR in
fluorescence-activated cell sorting-purified cells (neuronal and
non-neuronal) in an independent PFC suicide replication cohort,
thus allowing us to distinguish the methylation signature of the
PSORS1C3-associated DMR in different brain cell types. Third,
recent research has implicated the importance of other DNA
modifications (i.e., 5-hydroxymethyl cytosine) in the brain.60 DNA
methylation, as measured in this study, cannot be distinguished
Figure 4. Modules of co-methylated loci are associated with both MDD suicide completers and SA PRS in brain region BA25. (a) Heatmap
representing correlations between ME of diagnosis-associated modules and phenotype traits (diagnosis, MDD PRS and SA PRS). Each row
represents a BA25 module, which is labelled with an arbitrary colour. Dark red indicates strong positive correlation, dark blue indicates strong
negative correlation and white indicates no correlation (see colour scale bar). Uncorrected P-values are given in parentheses. The darkorange2
(P= 0.02) and white (P= 0.04) modules are also significantly associated with SA PRS in the BA25 brain region. (b) Boxplots and scatterplots of
ME against diagnosis (control versus MDD suicide) and SA PRS, respectively. (c) Co-methylation networks between hub loci (module
membership⩾ 0.8) in the white module, where larger circles indicate higher connectivity. Dark blue colour indicates a smaller P-value
obtained from the probewise regression analysis examining the relationship between probes/genes and diagnosis (MDD suicide cases
compared with controls), whereas white indicates a larger P-value. (d) Co-methylation networks between hub loci in the darkorange2 module,
where larger circles indicate higher connectivity. Dark orange colour indicates a smaller P-value obtained from the probewise regression
analysis examining the relationship between probes/genes and diagnosis (MDD suicide cases compared with controls), whereas white
indicates a larger P-value. BA25, Brodmann Area 25; MDD, major depressive disorder; ME, module eigengene; PRS, polygenic risk score; SA,
suicide attempt.
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from 5-hydroxymethyl cytosine, and it is therefore plausible that
the differences identified in this study are confounded by
modifications other than DNA methylation. Future studies should
attempt to examine the role of 5-hydroxymethyl cytosine in major
depression and suicidal behaviour. Fourth, medication data were
not available for all individuals; thus, we cannot rule out the
possibility that the observed DNA methylation changes are
confounded by medication. Finally, although our study presents
evidence for novel DNA methylation changes associated with
depressed suicide completers, further replication using a larger
sample size is required to support these results. In addition, future
studies could also examine the transcriptional consequences of
the observed DNA methylation changes.
In summary, our data have identified a DMR, upstream of the
PSORS1C3 non-coding gene, which is consistently hypomethylated
across both cortical brain regions in MDD suicide cases compared
with controls and has identified MDD suicide-associated co-
methylation modules that are specifically associated with suicide
attempt PRS but not a MDD PRS.
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